Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
02/2010
02/24/2010EP2155715A1 ((phenyl)imidazolyl)methylheteroaryl compounds
02/24/2010EP2155714A2 Substituted aromatic heterocyclic compounds as fungicides
02/24/2010EP2155687A1 Diacylglycerol acyltransferase inhibitors
02/24/2010EP2155678A1 New bradykinin b1 antagonists
02/24/2010EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
02/24/2010EP1971580B1 Piperazine compounds with a herbicidal action
02/24/2010EP1742935B1 Polycyclic pyrazines as potassium ion channel modulators
02/24/2010EP1625121B1 Pyrimidine derivatives for the treatment of abnormal cell growth
02/24/2010EP1585728B1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
02/24/2010EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use
02/24/2010CN101657445A Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
02/24/2010CN100591676C 2- and 2,5-substituted phenylketo-enols
02/23/2010US7667044 treating nervous system diorders such as Alzheimer's disease, Down Syndrome, Parkinson disease and Huntington chorea by administering inhibitors of prolyl endopeptidases
02/23/2010US7667042 Stable polymorphic forms of an anticonvulsant
02/23/2010US7667041 Cinnamide compound
02/23/2010US7666904 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof
02/23/2010US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
02/23/2010US7666869 Nitrogen-containing 5-membered ring compound
02/23/2010US7666863 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
02/23/2010CA2433021C Isoindole-imide compounds, compositions, and uses thereof
02/23/2010CA2345146C Cyanophenyl derivative
02/18/2010WO2010019930A1 Urea derivatives as inhibitors of map kinases
02/18/2010WO2010018329A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
02/18/2010WO2010017827A1 6-substituted 1-sulfonyl-2, 3-dihydro-indole derivatives for the treatment of proliferative diseases
02/18/2010US20100041891 Amide compound
02/18/2010US20100041730 Alkylated heterocyclic reaction products useful as antioxidants
02/18/2010US20100041726 INHIBITORS OF Akt ACTIVITY
02/18/2010US20100041667 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
02/18/2010US20100041656 Novel amide derivatives and medicinal use thereof
02/18/2010US20100041654 Pyrimidine Derivatives And Their Use As CB2 Modulators
02/18/2010US20100041652 Tyrosine kinase inhibitors
02/18/2010US20100041642 Urea inhibitors of map kinases
02/18/2010US20100041555 3-Phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same
02/18/2010US20100039025 Electrochromic materials and electrochromic devices using the same
02/18/2010CA2734082A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
02/17/2010EP2154130A1 Pyridone compound
02/17/2010EP2153832A2 Heterocyclic aspartyl protease inhibitors
02/17/2010EP2152699A1 Quinolone compound and pharmaceutical composition
02/17/2010EP2152674A1 Benzimidazolone chymase inhibitors
02/17/2010EP2152671A1 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
02/17/2010EP2152664A1 Dipeptide analogs as coagulation factor inhibitors
02/17/2010EP1902026B1 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
02/17/2010CN101648944A 病毒聚合酶抑制剂 Viral polymerase inhibitors
02/16/2010US7662845 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
02/16/2010US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid
02/16/2010US7662834 Methods of 1H-indol-3-yl-2-oxoacetamide compounds
02/16/2010US7662828 Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds
02/16/2010US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma
02/16/2010US7662818 e.g. 4-[5-(piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis
02/16/2010US7662816 Cognition activators; neurodegenerative disorders; Alzheimer's disease
02/16/2010US7662811 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use
02/16/2010US7662771 Drug delivery; controlled/sustained release
02/16/2010CA2478183C Substituted amides
02/16/2010CA2450922C Piperidines for use as orexin receptor antagonists
02/16/2010CA2385938C Cyclic amine compounds as ccr5 antagonists
02/16/2010CA2381009C Substituted thienyl(amino)sulfonylureas
02/11/2010WO2010017545A2 Triazole compounds that modulate hsp90 activity
02/11/2010WO2010017401A1 Bi-1h-benzimidazoles as hepatitis c virus inhibitors
02/11/2010WO2010017323A1 Novel methylenedioxy phenolic compounds and their use to treat disease
02/11/2010WO2010017272A2 Method of treating neurological diseases
02/11/2010WO2010016612A1 Dye for dye-sensitized solar cell, semiconductor electrode, and dye-sensitized solar cell
02/11/2010WO2010016549A1 Tricyclic compound
02/11/2010WO2010016230A1 Sulfoxyimino-substituted benzoyl derivative and herbicide
02/11/2010WO2010015169A1 A process for preparing eprosartan mesylate
02/11/2010WO2009017719A8 Modulators of ccr9 receptor and methods of use thereof
02/11/2010WO2003018547A3 An improved process for the preparation of amorphous atorvastatin calcium salt (2:1)
02/11/2010US20100035962 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof
02/11/2010US20100035961 Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof
02/11/2010US20100035948 Furanone compounds and lactam analogues thereof
02/11/2010US20100035929 Unnatural dispyrin analogues, preparation and uses thereof
02/11/2010US20100035879 N-sulfonylcarboximidamide apoptosis promoters
02/11/2010US20100035849 Novel methylenedioxy phenolic compounds and their use to treat disease
02/11/2010US20100035272 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
02/11/2010DE112008000841T5 Verbindung, photoelektrischer Wandler und photoelektrochemische Zelle Compound photoelectric transducer and photo-electrochemical cell
02/11/2010CA2733430A1 Novel methylenedioxy phenolic compounds and their use to treat disease
02/10/2010EP1963896B1 Photochromic materials having electron-withdrawing substituents
02/10/2010EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/10/2010CN101646667A Inhibitors of hepatitis C virus
02/10/2010CN101643470A Alkyl ether derivatives or salts thereof
02/09/2010US7659407 Pharmaceutical compounds
02/09/2010US7659298 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting
02/09/2010US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders
02/09/2010CA2557576C Novel benzothiazepine and benzothiepine compounds
02/09/2010CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications
02/09/2010CA2315646C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
02/09/2010CA2291065C Raf kinase inhibitors
02/09/2010CA2274201C Di-or triaza-spiro[4,5]decane derivatives
02/09/2010CA2268403C Anthranilic acid derivatives as multi drug resistance modulators
02/09/2010CA2218369C Transdermal electrotransport delivery of fentanyl and sufentanil
02/09/2010CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
02/04/2010WO2010014611A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
02/04/2010WO2010013510A1 Process for production of optically active compound
02/04/2010WO2010013222A1 Pyrrole carboxylic acid derivatives as antibacterial agents
02/04/2010WO2010012964A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
02/04/2010WO2010012806A2 Substituted indole sulfonamide compounds, their preparation and use as medicaments
02/04/2010WO2010012740A1 5-alkynyl-pyrimidines
02/04/2010WO2010012710A1 Perylene tetracarboximide derivatives for photovoltaic devices
02/04/2010WO2010012442A2 Insecticidal benzenedicarboxamide derivative
02/04/2010WO2010012397A1 N-(indol-3-ylalkyl)(hetero)arylamide derivatives as modulators of the ep2 receptor